IBMedical: what changed
IBMedical
Largest movements
- Cash -€415,814
down €415,814 (-95.0%), from €437,477 to €21,662
mainly Contributions, distributions and other (-€520,000) and Current investments (-€384,026)
- Current investments +€384,026
new in 2025: €384,026
- Financial fixed assets +€290,050
up €290,050 (+354%), from €82,000 to €372,050
- Deferred charges and accrued income -€33,593
down €33,593 (-74.7%), from €45,000 to €11,407
- Receivables after one year +€12,493
up €12,493 (+5.5%), from €227,738 to €240,231
- Other debts +€450,345
up €450,345 (+528%), from €85,347 to €535,692
- Profit (loss) carried forward -€175,442
down €175,442 (-25.6%), from €684,288 to €508,847
- Tax, wage and social debts -€48,450
down €48,450 (-67.2%), from €72,124 to €23,674
- Provisions +€14,915
new in 2025: €14,915
- Depreciation -€491,707
down €491,707 (-98.3%), from €500,335 to €8,629
- Gross operating margin -€405,151
down €405,151 (-45.4%), from €891,651 to €486,500
- Write-downs -€104,500
no longer reported in 2025 (was €104,500)
- Taxes +€45,507
up €45,507 (+61.4%), from €74,166 to €119,673
- Provisions +€29,019
up €29,019, from -€14,105 to €14,915
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €844,759 | €1,087,162 | +€242,403 | +28.7% |
| Fixed assets | 21/28 | €124,544 | €409,836 | +€285,292 | +229% |
| Tangible fixed assets | 22/27 | €42,544 | €37,786 | -€4,759 | -11.2% |
| Land and buildings | 22 | €27,319 | €30,523 | +€3,204 | +11.7% |
| Furniture and vehicles | 24 | €15,225 | €7,263 | -€7,962 | -52.3% |
| Financial fixed assets | 28 | €82,000 | €372,050 | +€290,050 | +354% |
| Current assets | 29/58 | €720,215 | €677,327 | -€42,888 | -6.0% |
| Amounts receivable after more than one year | 29 | €227,738 | €240,231 | +€12,493 | +5.5% |
| Other amounts receivable | 291 | €227,738 | €240,231 | +€12,493 | +5.5% |
| Amounts receivable within one year | 40/41 | €10,000 | €20,000 | +€10,000 | +100% |
| Other amounts receivable | 41 | €10,000 | €20,000 | +€10,000 | +100% |
| Current investments | 50/53 | - | €384,026 | +€384,026 | |
| Cash at bank and in hand | 54/58 | €437,477 | €21,662 | -€415,814 | -95.0% |
| Deferred charges and accrued income | 490/1 | €45,000 | €11,407 | -€33,593 | -74.7% |
| Total equity and liabilities | 10/49 | €844,759 | €1,087,162 | +€242,403 | +28.7% |
| Equity | 10/15 | €687,288 | €511,847 | -€175,442 | -25.5% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €684,288 | €508,847 | -€175,442 | -25.6% |
| Provisions and deferred taxes | 16 | - | €14,915 | +€14,915 | |
| Provisions for liabilities and charges | 160/5 | - | €14,915 | +€14,915 | |
| Other liabilities and charges | 164/5 | - | €14,915 | +€14,915 | |
| Amounts payable | 17/49 | €157,471 | €560,401 | +€402,930 | +256% |
| Amounts payable within one year | 42/48 | €157,471 | €560,401 | +€402,930 | +256% |
| Trade debts | 44 | - | €1,036 | +€1,036 | |
| Suppliers | 440/4 | - | €1,036 | +€1,036 | |
| Taxes, remuneration and social security | 45 | €72,124 | €23,674 | -€48,450 | -67.2% |
| Taxes | 450/3 | €72,124 | €23,674 | -€48,450 | -67.2% |
| Other amounts payable | 47/48 | €85,347 | €535,692 | +€450,345 | +528% |
| Non-recurring operating income | 76A | €525,380 | €3,870 | -€521,509 | -99.3% |
| Remuneration, social security and pensions | 62 | - | €3,480 | +€3,480 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €500,335 | €8,629 | -€491,707 | -98.3% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €104,500 | - | -€104,500 | |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | -€14,105 | €14,915 | +€29,019 | |
| Other operating charges | 640/8 | €1,092 | €528 | -€564 | -51.6% |
| Gross operating margin | 9900 | €891,651 | €486,500 | -€405,151 | -45.4% |
| Operating profit (loss) | 9901 | €299,828 | €458,948 | +€159,121 | +53.1% |
| Financial income | 75/76B | €6,901 | €12,493 | +€5,592 | +81.0% |
| Recurring financial income | 75 | €6,901 | €12,493 | +€5,592 | +81.0% |
| Financial charges | 65/66B | €19,632 | €7,210 | -€12,422 | -63.3% |
| Recurring financial charges | 65 | €19,632 | €7,210 | -€12,422 | -63.3% |
| Profit (loss) for the period before taxes | 9903 | €287,097 | €464,231 | +€177,134 | +61.7% |
| Income taxes | 67/77 | €74,166 | €119,673 | +€45,507 | +61.4% |
| Profit (loss) for the period | 9904 | €212,931 | €344,558 | +€131,627 | +61.8% |
| Profit (loss) for the period to be appropriated | 9905 | €212,931 | €344,558 | +€131,627 | +61.8% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.